Grifols SA (GRFS)

Nasdaq Pharmaceutical Pharmaceutical Preparations SIC: 2834
D
Pipeline Grade

Drug Pipeline (0 Assets)

No drugs indexed yet. Pipeline data is populated from ClinicalTrials.gov and openFDA.

Upcoming Catalysts

DateEventDrug
2026-08-01 Phase3 Readout

Active Clinical Trials (1)

NCT #TitlePhaseStatusEnrollment
NCT01983241 Efficacy and Safety of Alpha1-Proteinase Inhibitor (Human), Modified Process (Alpha-1 MP) in Subjects With Pulmonary Emp... PHASE3 Active Not Recruiting 345

Source: ClinicalTrials.gov. Trial status last updated by sponsor — may not reflect current state.

More Analysis